ResMed Inc. logo

ResMed Inc. (RME)

Market Open
9 Jun, 06:01
XMUN XMUN
219. 80
+1.9
+0.87%
- Market Cap
27.49 P/E Ratio
1.92% Div Yield
0 Volume
6.52 Eps
217.9
Previous Close
Day Range
219.8 219.8
Year Range
170.15 242.7
Earnings results expected in 51 days

Summary

RME trading today higher at €219.8, an increase of 0.87% from yesterday's close, completing a monthly increase of 5.52% or €11.5. Over the past 12 months, RME stock lost -0.9%.
RME pays dividends to its shareholders, with the most recent payment made on Mar 20, 2025. The next announced payment will be in In 3 days on Jun 12, 2025 for a total of €0.53.
The last earnings report, released on Apr 23, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports. The next scheduled earnings report is due on Jul 30, 2025.
The stock of the company had never split.
The company's stock is traded on 11 different exchanges and in various currencies, with the primary listing on NYSE (USD).
Want to track RME and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

RME Chart

Chart

Empty chart
The chart has 2 Y axes displaying values, and values.
Loading, please wait...
End of interactive chart.
ResMed: A Sleeping Giant Hiding In Plain Sight

ResMed: A Sleeping Giant Hiding In Plain Sight

ResMed dominates an enormous, underdiagnosed market with recurring revenue and digital health leadership, yet trades below its historical earnings multiples, offering compelling value. The company's sticky, essential products and expanding digital platform create a powerful, recession-resistant business model with strong secular tailwinds. We forecast 10% compound annual growth through 2030, with shares offering 13-21% upside based on reasonable valuation multiples and robust earnings growth.

Seekingalpha | 6 hours ago
ResMed (RMD) Up 4% Since Last Earnings Report: Can It Continue?

ResMed (RMD) Up 4% Since Last Earnings Report: Can It Continue?

ResMed (RMD) reported earnings 30 days ago. What's next for the stock?

Zacks | 2 weeks ago
Is it Worth Retaining ResMed Stock in Your Portfolio Now?

Is it Worth Retaining ResMed Stock in Your Portfolio Now?

RMD gains on strong mask sales and digital health growth, but faces macro headwinds and fierce competition.

Zacks | 2 weeks ago

ResMed Inc. (RME) FAQ

What is the stock price today?

The current price is €219.80.

On which exchange is it traded?

ResMed Inc. is listed on NYSE.

What is its stock symbol?

The ticker symbol is RME.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

What is the earnings per share?

The EPS is 0.

When is the next earnings date?

The next earnings report will release on Jul 30, 2025.

Has ResMed Inc. ever had a stock split?

ResMed Inc. had 0 splits and the recent split was on Aug 31, 2010.

ResMed Inc. Profile

Medical - Instruments & Supplies Industry
Healthcare Sector
Mr. Michael J. Farrell BE, MBA, SM CEO
XMUN Exchange
US7611521078 ISIN
US Country
10,140 Employees
13 Feb 2025 Last Dividend
31 Aug 2010 Last Split
2 Jun 1995 IPO Date

Overview

ResMed Inc. is a pioneering company focused on developing, manufacturing, distributing, and marketing medical devices alongside cloud-based software applications tailored for the healthcare markets. With its operational base divided between Sleep and Respiratory Care, and Software as a Service (SaaS), ResMed is at the forefront of offering innovative solutions for managing respiratory disorders. The company's extensive product lineup and software solutions cater to both medical and consumer needs, aiming to improve patient outcomes through advanced technology and connectivity. Founded in 1989 and headquartered in San Diego, California, ResMed markets its products globally through a combination of direct sales forces and a network of distributors, targeting sleep clinics, home healthcare dealers, and hospitals.

Products and Services

  • Technologies for Respiratory Disorders - ResMed offers an array of products for treating various respiratory disorders, including ventilation devices, diagnostic products, and mask systems for use in hospitals and homes. These products are complemented by headgear, accessories, and dental devices, integrating cutting-edge technology for both medical and consumer applications.
  • Cloud-Based Software Informatics - The company's software solutions, such as AirView and myAir, facilitate remote monitoring and management of patient outcomes. AirView allows healthcare professionals to remotely monitor and adjust patients' device settings, while myAir, a personalized therapy management app, supports patients with sleep apnea through education, troubleshooting tools, and engagement strategies to improve compliance.
  • U-Sleep Compliance Monitoring - U-Sleep is a solution designed to help home medical equipment (HME) providers streamline their sleep programs by efficiently monitoring patient compliance, an essential factor for successful therapy outcomes.
  • Out-of-Hospital Software Solutions - ResMed provides various software solutions like Brightree, MatrixCare, HEALTHCAREfirst, and MEDIFOX DAN, catering to the business management and caregiving needs of HME providers, pharmacies, senior living facilities, skilled nursing facilities, and hospice organizations. These solutions include business management software, electronic health records, billing, coding services, and analytics, facilitating improved care delivery and operational efficiency.

Contact Information

Address: 9001 Spectrum Center Boulevard
Phone: 858 836 5000